首页 > 最新文献

Journal of the ASEAN Federation of Endocrine Societies最新文献

英文 中文
Evaluation of Type 2 Diabetes Risk Variants (Alleles) in the Pashtun Ethnic Population of Pakistan. 巴基斯坦普什图族人群2型糖尿病风险变异(等位基因)的评估
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.15605/jafes.037.S3
Asif Jan, Muhammad Saeed, Zakiullah, Rani Akbar, Hamayun Khan

Objective: To evaluate the Type 2 Diabetes (T2D) risk variants in the Pashtun ethnic population of Khyber Pakhtunkhwa using nascent whole-exome sequencing (WES) to better understand the pathogenesis of this complex polygenic disorder.

Methodology: A total of 100 confirmed patients with T2D of Pashtun ethnicity were included in the study, DNA was extracted from whole blood samples, and paired-end libraries were prepared using the Illumina Nextera XT DNA library kit carefully following the manufacturer's instructions. Illumina HiSeq 2000 was used to obtain sequences of the prepared libraries followed by bioinformatics data analysis.

Results: A total of n=11 pathogenic/likely pathogenic variants were reported in the CAP10, PAX4, IRS-2, NEUROD1, CDKL1 and WFS1. Among the reported variants CAP10/rs55878652 (c.1990-7T>C; p.Leu446Pro) and CAP10/rs2975766 (c.1996A>G; p.Ile666Val) identified were novel, and have not yet been reported for any disease in the database.The variants CAP10/rs7607759 (c.1510A>G, p.Thr504Ala), PAX4/rs712701 (c.962A>C; p.His321Pro), PAX4/rs772936097 (c.748-3delT; p.Arg325Trp), IRS-2/rs1805097 (c.3170G>A; p.Gly1057Asp), NEUROD1/rs1801262 (c.133A>G; p.Thr45Ala), CDKL1/rs77152992 (c.1226C>T; p.Pro409Leu), WFS1/rs1801212 (c.997G>A; p.Val333Ile), WFS1/rs1801208 (c.1367G>A; p.Arg456His), and WFS1/rs734312 (c.1832G>A; p.Arg611His) are previously identified in other ethnic populations. Our study reconfirms the associations of these variants with T2D in the Pakistani Pashtun population.

Conclusion: In-silico analysis of exome sequencing data suggests a statistically substantial association of all (n=11) identified variants with T2D in the Pashtun ethnic population. This study may serve as a foundation for performing future molecular studies aimed at unraveling T2D associated genes.

目的:利用新兴全外显子组测序(WES)评估开伯尔-普赫图赫瓦普什图族人群中2型糖尿病(T2D)风险变异,以更好地了解这一复杂多基因疾病的发病机制。方法:共纳入100例确诊的普什图族T2D患者,从全血样本中提取DNA,使用Illumina Nextera XT DNA文库试剂盒严格按照制造商的说明制备成对端文库。利用Illumina HiSeq 2000对制备的文库进行测序,并进行生物信息学数据分析。结果:CAP10、PAX4、IRS-2、NEUROD1、CDKL1和WFS1共报告了n=11个致病/可能致病变异。在报告的变体CAP10/rs55878652 (C .1990- 7t >C;p.Leu446Pro)和CAP10/rs2975766 (c.1996A>G;发现的p.e ile666val)是新颖的,并且尚未在数据库中报告任何疾病。CAP10/rs7607759 (C . 1510a >G, p.Thr504Ala), PAX4/rs712701 (C . 962a >C;p.His321Pro), PAX4/rs772936097 (c.748-3delT;p.Arg325Trp), IRS-2/rs1805097 (c.3170G>A;p.Gly1057Asp), NEUROD1/rs1801262 (c.133A>G;p.Thr45Ala), CDKL1/rs77152992 (c.1226C>T;p.Pro409Leu), WFS1/rs1801212 (c.997G>A;p.Val333Ile), WFS1/rs1801208 (c.1367G>A;p.Arg456His)和WFS1/rs734312 (c.1832G>A;p.Arg611His)先前在其他种族人群中被发现。我们的研究再次证实了这些变异与巴基斯坦普什图人群中T2D的关联。结论:外显子组测序数据的计算机分析表明,在普什图族人群中,所有(n=11)个已确定的变异与T2D存在统计学上的显著关联。该研究可能为开展旨在揭示T2D相关基因的未来分子研究奠定基础。
{"title":"Evaluation of Type 2 Diabetes Risk Variants (Alleles) in the Pashtun Ethnic Population of Pakistan.","authors":"Asif Jan,&nbsp;Muhammad Saeed,&nbsp;Zakiullah,&nbsp;Rani Akbar,&nbsp;Hamayun Khan","doi":"10.15605/jafes.037.S3","DOIUrl":"https://doi.org/10.15605/jafes.037.S3","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the Type 2 Diabetes (T2D) risk variants in the Pashtun ethnic population of Khyber Pakhtunkhwa using nascent whole-exome sequencing (WES) to better understand the pathogenesis of this complex polygenic disorder.</p><p><strong>Methodology: </strong>A total of 100 confirmed patients with T2D of Pashtun ethnicity were included in the study, DNA was extracted from whole blood samples, and paired-end libraries were prepared using the Illumina Nextera XT DNA library kit carefully following the manufacturer's instructions. Illumina HiSeq 2000 was used to obtain sequences of the prepared libraries followed by bioinformatics data analysis.</p><p><strong>Results: </strong>A total of n=11 pathogenic/likely pathogenic variants were reported in the CAP10, PAX4, IRS-2, NEUROD1, CDKL1 and WFS1. Among the reported variants CAP10/rs55878652 (c.1990-7T>C; p.Leu446Pro) and CAP10/rs2975766 (c.1996A>G; p.Ile666Val) identified were novel, and have not yet been reported for any disease in the database.The variants CAP10/rs7607759 (c.1510A>G, p.Thr504Ala), PAX4/rs712701 (c.962A>C; p.His321Pro), PAX4/rs772936097 (c.748-3delT; p.Arg325Trp), IRS-2/rs1805097 (c.3170G>A; p.Gly1057Asp), NEUROD1/rs1801262 (c.133A>G; p.Thr45Ala), CDKL1/rs77152992 (c.1226C>T; p.Pro409Leu), WFS1/rs1801212 (c.997G>A; p.Val333Ile), WFS1/rs1801208 (c.1367G>A; p.Arg456His), and WFS1/rs734312 (c.1832G>A; p.Arg611His) are previously identified in other ethnic populations. Our study reconfirms the associations of these variants with T2D in the Pakistani Pashtun population.</p><p><strong>Conclusion: </strong>In-silico analysis of exome sequencing data suggests a statistically substantial association of all (n=11) identified variants with T2D in the Pashtun ethnic population. This study may serve as a foundation for performing future molecular studies aimed at unraveling T2D associated genes.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 1","pages":"48-54"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/42/JAFES-38-S1-48.PMC10207872.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9598988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Bisphenol S Increases Cell Number and Stimulates Migration of Endometrial Epithelial Cells. 双酚S增加子宫内膜上皮细胞数量并刺激其迁移。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.15605/jafes.037.S7
Kimberly Benjamin, Cielo Mae Marquez, Madeleine Morta, Emmanuel Marc Reyes, Lemnuel Aragones, Michael Velarde

Objective: To determine whether bisphenol S (BPS), a common substitute for bisphenol A (BPA), induces cell proliferation and migration in human endometrial epithelial cells (Ishikawa) and adult mouse uterine tissues.

Methodology: Human endometrial Ishikawa cells were exposed to low doses of BPS (1 nM and 100 nM) for 72 hours. Cell proliferation was assessed through the viability assays MTT and CellTiter-Glo®. Wound healing assays were also used to evaluate the migration potential of the cell line. The expression of genes related to proliferation and migration was also determined. Similarly, adult mice were exposed to BPS at a dose of 30 mg/kg body weight/day for 21 days, after which, the uterus was sent for histopathologic assessment.

Results: BPS increased cell number and stimulated migration in Ishikawa cells, in association with the upregulation of estrogen receptor beta (ESR2) and vimentin (VIM). In addition, mice exposed to BPS showed a significantly higher mean number of endometrial glands within the endometrium.

Conclusion: Overall, in vitro and in vivo results obtained in this study showed that BPS could significantly promote endometrial epithelial cell proliferation and migration, a phenotype also observed with BPA exposure. Hence, the use of BPS in BPA-free products must be reassessed, as it may pose adverse reproductive health effects to humans.

目的:探讨双酚a (BPA)的常用替代品双酚S (BPS)对人子宫内膜上皮细胞(Ishikawa)和成年小鼠子宫组织中细胞增殖和迁移的诱导作用。方法:将人子宫内膜石川细胞暴露于低剂量BPS (1 nM和100 nM)中72小时。通过MTT和CellTiter-Glo®活性测定法评估细胞增殖。伤口愈合试验也用于评估细胞系的迁移潜力。同时还测定了与增殖和迁移相关的基因的表达。同样,成年小鼠以30 mg/kg体重/天的剂量暴露于BPS 21天,之后送子宫进行组织病理学评估。结果:BPS增加石川细胞的细胞数量,刺激细胞迁移,与雌激素受体β (ESR2)和vimentin (VIM)的上调有关。此外,暴露于BPS的小鼠显示子宫内膜内子宫内膜腺的平均数量显着增加。结论:总体而言,本研究获得的体外和体内结果表明,BPS可以显著促进子宫内膜上皮细胞的增殖和迁移,BPA暴露也可以观察到这种表型。因此,必须重新评估在不含双酚a产品中使用双酚a的情况,因为它可能对人类的生殖健康造成不利影响。
{"title":"Bisphenol S Increases Cell Number and Stimulates Migration of Endometrial Epithelial Cells.","authors":"Kimberly Benjamin,&nbsp;Cielo Mae Marquez,&nbsp;Madeleine Morta,&nbsp;Emmanuel Marc Reyes,&nbsp;Lemnuel Aragones,&nbsp;Michael Velarde","doi":"10.15605/jafes.037.S7","DOIUrl":"https://doi.org/10.15605/jafes.037.S7","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether bisphenol S (BPS), a common substitute for bisphenol A (BPA), induces cell proliferation and migration in human endometrial epithelial cells (Ishikawa) and adult mouse uterine tissues.</p><p><strong>Methodology: </strong>Human endometrial Ishikawa cells were exposed to low doses of BPS (1 nM and 100 nM) for 72 hours. Cell proliferation was assessed through the viability assays MTT and CellTiter-Glo<sup>®</sup>. Wound healing assays were also used to evaluate the migration potential of the cell line. The expression of genes related to proliferation and migration was also determined. Similarly, adult mice were exposed to BPS at a dose of 30 mg/kg body weight/day for 21 days, after which, the uterus was sent for histopathologic assessment.</p><p><strong>Results: </strong>BPS increased cell number and stimulated migration in Ishikawa cells, in association with the upregulation of estrogen receptor beta <i>(ESR2)</i> and vimentin <i>(VIM)</i>. In addition, mice exposed to BPS showed a significantly higher mean number of endometrial glands within the endometrium.</p><p><strong>Conclusion: </strong>Overall, <i>in vitro</i> and <i>in vivo</i> results obtained in this study showed that BPS could significantly promote endometrial epithelial cell proliferation and migration, a phenotype also observed with BPA exposure. Hence, the use of BPS in BPA-free products must be reassessed, as it may pose adverse reproductive health effects to humans.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 1","pages":"13-22"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/82/9f/JAFES-38-S1-13.PMC10207871.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9598991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Going PubMed, Writing Together! 去PubMed,一起写作!
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.15605/jafes.038.01.01
Elizabeth Paz-Pacheco
{"title":"Going PubMed, Writing Together!","authors":"Elizabeth Paz-Pacheco","doi":"10.15605/jafes.038.01.01","DOIUrl":"https://doi.org/10.15605/jafes.038.01.01","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 1","pages":"4"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a9/28/JAFES-38-1-4.PMC10213159.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9589868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia. 家族纯合子型高胆固醇血症并发多发性结节黄色瘤1例。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.15605/jafes.038.01.17
Pankaj Singhania, Pritam Biswas, Abhranil Dhar
{"title":"Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia.","authors":"Pankaj Singhania,&nbsp;Pritam Biswas,&nbsp;Abhranil Dhar","doi":"10.15605/jafes.038.01.17","DOIUrl":"https://doi.org/10.15605/jafes.038.01.17","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 1","pages":"134-135"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/7d/JAFES-38-1-134.PMC10213381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9589870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Acute Hyperglycemia and Diabetes Mellitus with Platelet-derived Microparticle (PDMP) Levels During Acute Myocardial Infarction. 急性高血糖和糖尿病与急性心肌梗死期间血小板衍生微粒(PDMP)水平的关系
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 Epub Date: 2023-07-30 DOI: 10.15605/jafes.038.02.03
Hana Anindya Indana, Ira Puspitawati, Dyah Samti Mayasari, Anggoro Budi Hartopo

Objectives: This research investigates whether there is an association between acute hyperglycemia and diabetes mellitus and the level of circulating platelet-derived microparticles (PDMPs) during an initial episode of acute myocardial infarction (AMI).

Methodology: This was a cross-sectional study involving hospitalized AMI patients. Demographic and clinical data were obtained from hospital records. Diabetes mellitus was defined by the history of the disease, anti-diabetes medication use and/ or level of HbA1C ≥6.5%. Levels of HbA1c, admission random and fasting blood glucose levels were measured. Flow-cytometry method was used to determine the levels of PDMPs from collected venous blood through tagging with CD-41 FITC and CD-62 PE markers and a threshold size of <1 μm. The number of circulating PDMPs was compared according to glucometabolic state, namely acute hyperglycemia (admission random glucose ≥200 mg/dL and fasting glucose ≥140 mg/dL) and diabetes mellitus. The comparative analysis between groups was conducted with Student T-test or Mann-Whitney test, where applicable.

Results: A total of 108 subjects were included and their data analyzed. The level of circulating PDMPs was significantly lower in subjects with admission random glucose ≥200 mg/dL as compared to those with below level [median (interquartile range (IQR)]: 2,710.0 (718.0-8,167.0) count/mL vs. 4,452.0 (2,128.5-14,499.8) count/mL, p = 0.05) and in subjects with fasting glucose ≥140 mg/dL as compared to those with below level (median (IQR): 2,382.0 (779.0-6,619.0) count/mL vs. 5,972.0 (2,345.7-14,781.3) count/mL, p = 0.006). The level of circulating PDMPs was also significantly lower in patients with diabetes mellitus as compared to those without (median (IQR): 2,655.0 (840.0-5,821.0) count/mL vs. 4,562.0 (2,128.5-15,055.8) count/mL; p = 0.007).

Conclusion: Acute hyperglycemia and diabetes mellitus are significantly associated with a lower circulating PDMP level during an initial AMI episode.

目的:本研究探讨急性高血糖和糖尿病与急性心肌梗死(AMI)初始发作时循环血小板衍生微粒(PDMPs)水平之间是否存在关联。方法:这是一项涉及住院AMI患者的横断面研究。人口统计和临床数据来自医院记录。糖尿病的定义是疾病史、抗糖尿病药物使用和/或HbA1C水平≥6.5%。测量HbA1c水平、入院随机和空腹血糖水平。采用流式细胞术方法,通过CD-41 FITC和CD-62 PE标记物和阈值大小,测定采集静脉血中PDMPs的水平。结果:共纳入108例受试者,并对其数据进行分析。循环PDMPs水平显著低于受试者承认随机血糖≥200 mg / dL如下相比那些水平(中位数(四分位范围(差):2710 .0 /毫升(718.0 -8167 .0)计数与4452 .0(2128 5 - 14499。8)计数/毫升,p = 0.05),在主体与空腹血糖≥140 mg / dL相比低水平(中位数(差):2382 .0 /毫升(779.0 -6619 .0)计数与5972 .0(2345 .7 - 14781 - 3)计数/ mL, p = 0.006)。与无糖尿病患者相比,糖尿病患者的循环PDMPs水平也显著降低(中位数(IQR): 2,655.0(84.0 -5,821.0)计数/mL vs. 4,562.0(2,128.5-15,055.8)计数/mL;P = 0.007)。结论:急性高血糖和糖尿病与AMI初始发作时较低的循环PDMP水平显著相关。
{"title":"Association of Acute Hyperglycemia and Diabetes Mellitus with Platelet-derived Microparticle (PDMP) Levels During Acute Myocardial Infarction.","authors":"Hana Anindya Indana, Ira Puspitawati, Dyah Samti Mayasari, Anggoro Budi Hartopo","doi":"10.15605/jafes.038.02.03","DOIUrl":"10.15605/jafes.038.02.03","url":null,"abstract":"<p><strong>Objectives: </strong>This research investigates whether there is an association between acute hyperglycemia and diabetes mellitus and the level of circulating platelet-derived microparticles (PDMPs) during an initial episode of acute myocardial infarction (AMI).</p><p><strong>Methodology: </strong>This was a cross-sectional study involving hospitalized AMI patients. Demographic and clinical data were obtained from hospital records. Diabetes mellitus was defined by the history of the disease, anti-diabetes medication use and/ or level of HbA1C ≥6.5%. Levels of HbA1c, admission random and fasting blood glucose levels were measured. Flow-cytometry method was used to determine the levels of PDMPs from collected venous blood through tagging with CD-41 FITC and CD-62 PE markers and a threshold size of <1 μm. The number of circulating PDMPs was compared according to glucometabolic state, namely acute hyperglycemia (admission random glucose ≥200 mg/dL and fasting glucose ≥140 mg/dL) and diabetes mellitus. The comparative analysis between groups was conducted with Student T-test or Mann-Whitney test, where applicable.</p><p><strong>Results: </strong>A total of 108 subjects were included and their data analyzed. The level of circulating PDMPs was significantly lower in subjects with admission random glucose ≥200 mg/dL as compared to those with below level [median (interquartile range (IQR)]: 2,710.0 (718.0-8,167.0) count/mL vs. 4,452.0 (2,128.5-14,499.8) count/mL, <i>p</i> = 0.05) and in subjects with fasting glucose ≥140 mg/dL as compared to those with below level (median (IQR): 2,382.0 (779.0-6,619.0) count/mL vs. 5,972.0 (2,345.7-14,781.3) count/mL, <i>p</i> = 0.006). The level of circulating PDMPs was also significantly lower in patients with diabetes mellitus as compared to those without (median (IQR): 2,655.0 (840.0-5,821.0) count/mL vs. 4,562.0 (2,128.5-15,055.8) count/mL; <i>p</i> = 0.007).</p><p><strong>Conclusion: </strong>Acute hyperglycemia and diabetes mellitus are significantly associated with a lower circulating PDMP level during an initial AMI episode.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 2","pages":"35-40"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692412/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac and Metabolic Effects of Bariatric Surgery Among Obese Patients in a Malaysian Tertiary Hospital: A 6-month Prospective Cohort Study. 马来西亚三级医院肥胖患者减肥手术对心脏和代谢的影响:一项为期6个月的前瞻性队列研究。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 Epub Date: 2023-08-24 DOI: 10.15605/jafes.038.02.23
Mohd Haidir Roslan, Mohd Asyiq Raffali, Shawal Faizal Mohamad, Nik Ritza Kosai Nik Mahmood, Hamat Hamdi Che Hassan

Objective: Obesity is known to be associated with left ventricular diastolic dysfunction due to its effect on blood pressure and glucose tolerance. We aimed to investigate whether weight loss after bariatric surgery might improve diastolic dysfunction through in-depth echocardiographic examination.

Methodology: We recruited twenty-eight patients who were about to undergo bariatric surgery by purposive sampling. They underwent echocardiography at baseline and 6 months after surgery with a focus on diastolic function measurements and global longitudinal strain (GLS). They also had fasting serum lipid and glucose measurements pre- and post-surgery.

Results: The mean weight loss after surgery was 24.1 kg. Out of the 28 subjects, fifteen (54%) initially had diastolic dysfunction before surgery. Only two had persistent diastolic dysfunction 6 months after surgery. The mean indexed left atrial volume 6 months post-surgery was 27.1 from 32 ml/m2 prior to surgery. The average E/e' is 11.78 post-surgery from 13.43 pre-surgery. The left ventricular GLS became (-)25.7% after surgery from (-)21.2% prior to surgery. Their post-surgery fasting serum lipid and glucose levels also showed significant improvement.

Conclusion: Our study reinforced the existing evidence that bariatric surgery significantly improved echocardiographic parameters of diastolic function and left ventricular global longitudinal strain, along with various metabolic profiles.

目的:已知肥胖与左心室舒张功能障碍有关,因为它会影响血压和葡萄糖耐量。我们的目的是通过深入的超声心动图检查,探讨减肥手术后体重减轻是否可以改善舒张功能障碍。方法:我们通过有目的的抽样方法招募了28名即将接受减肥手术的患者。他们在基线和手术后6个月接受超声心动图检查,重点是舒张功能测量和整体纵向应变(GLS)。他们还在术前和术后进行了空腹血脂和血糖测量。结果:术后平均体重减轻24.1 kg。在28例受试者中,15例(54%)术前最初有舒张功能不全。只有2例术后6个月持续舒张功能不全。术后6个月左心房平均指数容积由术前的32 ml/m2下降到27.1。术后平均E/ E′为11.78,术前为13.43。左心室GLS由术前的(-)21.2%变为术后的(-)25.7%。术后空腹血脂和血糖水平也有明显改善。结论:我们的研究强化了现有的证据,即减肥手术显著改善了舒张功能和左心室总纵应变的超声心动图参数,以及各种代谢谱。
{"title":"Cardiac and Metabolic Effects of Bariatric Surgery Among Obese Patients in a Malaysian Tertiary Hospital: A 6-month Prospective Cohort Study.","authors":"Mohd Haidir Roslan, Mohd Asyiq Raffali, Shawal Faizal Mohamad, Nik Ritza Kosai Nik Mahmood, Hamat Hamdi Che Hassan","doi":"10.15605/jafes.038.02.23","DOIUrl":"10.15605/jafes.038.02.23","url":null,"abstract":"<p><strong>Objective: </strong>Obesity is known to be associated with left ventricular diastolic dysfunction due to its effect on blood pressure and glucose tolerance. We aimed to investigate whether weight loss after bariatric surgery might improve diastolic dysfunction through in-depth echocardiographic examination.</p><p><strong>Methodology: </strong>We recruited twenty-eight patients who were about to undergo bariatric surgery by purposive sampling. They underwent echocardiography at baseline and 6 months after surgery with a focus on diastolic function measurements and global longitudinal strain (GLS). They also had fasting serum lipid and glucose measurements pre- and post-surgery.</p><p><strong>Results: </strong>The mean weight loss after surgery was 24.1 kg. Out of the 28 subjects, fifteen (54%) initially had diastolic dysfunction before surgery. Only two had persistent diastolic dysfunction 6 months after surgery. The mean indexed left atrial volume 6 months post-surgery was 27.1 from 32 ml/m<sup>2</sup> prior to surgery. The average E/e' is 11.78 post-surgery from 13.43 pre-surgery. The left ventricular GLS became (-)25.7% after surgery from (-)21.2% prior to surgery. Their post-surgery fasting serum lipid and glucose levels also showed significant improvement.</p><p><strong>Conclusion: </strong>Our study reinforced the existing evidence that bariatric surgery significantly improved echocardiographic parameters of diastolic function and left ventricular global longitudinal strain, along with various metabolic profiles.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 2","pages":"94-100"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692411/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Persistent Primary Hyperparathyroidism Secondary to an Ectopic Mediastinal Adenoma in a Young Adult: A Case Report. 继发于异位纵隔腺瘤的持续性原发性甲状旁腺功能亢进1例。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 Epub Date: 2023-07-15 DOI: 10.15605/jafes.038.02.16
Karl Homer Nievera, Rebecca Alba

Primary hyperparathyroidism commonly affects elderly women. When present in the young population, it is usually asymptomatic, most frequently due to a parathyroid adenoma and the definitive management is surgical excision. Uncommonly, 5-10% of patients fail to achieve long-term cure after initial parathyroidectomy and 6-16% of them is due to an ectopic parathyroid adenoma that will require focused diagnostic and surgical approaches. We report a 21-year-old male who had bilateral thigh pain. Work-up revealed bilateral femoral fractures, brown tumors on the arms and multiple lytic lesions on the skull. Serum studies showed hypercalcemia (1.83 mmol/L), elevated parathyroid hormone [(PTH) 2025.10 pg/mL], elevated alkaline phosphatase (830 U/L), normal phosphorus (0.92 mmol/L) and low vitamin D levels (18.50 ng/mL). Bone densitometry showed osteoporotic findings. Sestamibi scan showed uptake on the left superior mediastinal region consistent with an ectopic parathyroid adenoma. Vitamin D supplementation was started pre-operatively. Patient underwent parathyroidectomy with neck exploration; however, the pathologic adenoma was not visualized and PTH levels remained elevated post-operatively. Chest computed tomography with intravenous contrast was performed revealing a mediastinal location of the adenoma. A repeat parathyroidectomy was done, with successful identification of the adenoma resulting in a significant drop in PTH and calcium levels. Patient experienced hungry bone syndrome post-operatively and was managed with calcium and magnesium supplementation. A high index of suspicion for an ectopic adenoma is warranted for patients presenting with hypercalcemia and secondary osteoporosis if there is persistent PTH elevation after initial surgical intervention. Adequate follow-up and monitoring is also needed starting immediately in the post-operative period to manage possible complications such as hungry bone syndrome.

原发性甲状旁腺功能亢进常见于老年妇女。当出现在年轻人群时,它通常是无症状的,最常见的是由于甲状旁腺瘤,最终的治疗是手术切除。罕见的是,5-10%的患者在初始甲状旁腺切除术后未能实现长期治愈,其中6-16%是由于异位甲状旁腺瘤,需要集中诊断和手术方法。我们报告一位21岁的男性,他有双侧大腿疼痛。检查发现双侧股骨骨折,手臂上有棕色肿瘤颅骨上有多处溶解性损伤。血清检查显示高钙血症(1.83 mmol/L)、甲状旁腺激素(PTH)升高(2025.10 pg/mL)、碱性磷酸酶升高(830 U/L)、磷正常(0.92 mmol/L)、维生素D低(18.50 ng/mL)。骨密度测定显示骨质疏松。Sestamibi扫描显示左侧上纵隔区摄取与异位甲状旁腺瘤一致。术前开始补充维生素D。患者行甲状旁腺切除术伴颈部探查;然而,病理性腺瘤未可见,术后甲状旁腺素水平仍然升高。胸部计算机断层扫描和静脉造影显示了腺瘤的纵隔位置。再次进行甲状旁腺切除术,成功识别腺瘤,导致甲状旁腺激素和钙水平显著下降。患者术后出现饥饿骨综合征,并给予钙镁补充治疗。对于出现高钙血症和继发性骨质疏松症的患者,如果在最初的手术干预后有持续的甲状旁腺激素升高,应高度怀疑异位腺瘤。术后也需要立即开始适当的随访和监测,以控制可能出现的并发症,如饥饿骨综合征。
{"title":"Persistent Primary Hyperparathyroidism Secondary to an Ectopic Mediastinal Adenoma in a Young Adult: A Case Report.","authors":"Karl Homer Nievera, Rebecca Alba","doi":"10.15605/jafes.038.02.16","DOIUrl":"10.15605/jafes.038.02.16","url":null,"abstract":"<p><p>Primary hyperparathyroidism commonly affects elderly women. When present in the young population, it is usually asymptomatic, most frequently due to a parathyroid adenoma and the definitive management is surgical excision. Uncommonly, 5-10% of patients fail to achieve long-term cure after initial parathyroidectomy and 6-16% of them is due to an ectopic parathyroid adenoma that will require focused diagnostic and surgical approaches. We report a 21-year-old male who had bilateral thigh pain. Work-up revealed bilateral femoral fractures, brown tumors on the arms and multiple lytic lesions on the skull. Serum studies showed hypercalcemia (1.83 mmol/L), elevated parathyroid hormone [(PTH) 2025.10 pg/mL], elevated alkaline phosphatase (830 U/L), normal phosphorus (0.92 mmol/L) and low vitamin D levels (18.50 ng/mL). Bone densitometry showed osteoporotic findings. Sestamibi scan showed uptake on the left superior mediastinal region consistent with an ectopic parathyroid adenoma. Vitamin D supplementation was started pre-operatively. Patient underwent parathyroidectomy with neck exploration; however, the pathologic adenoma was not visualized and PTH levels remained elevated post-operatively. Chest computed tomography with intravenous contrast was performed revealing a mediastinal location of the adenoma. A repeat parathyroidectomy was done, with successful identification of the adenoma resulting in a significant drop in PTH and calcium levels. Patient experienced hungry bone syndrome post-operatively and was managed with calcium and magnesium supplementation. A high index of suspicion for an ectopic adenoma is warranted for patients presenting with hypercalcemia and secondary osteoporosis if there is persistent PTH elevation after initial surgical intervention. Adequate follow-up and monitoring is also needed starting immediately in the post-operative period to manage possible complications such as hungry bone syndrome.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 2","pages":"145-148"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand. 在接受靶向治疗的癌症患者中甲状腺功能障碍的患病率及相关因素:来自泰国的一项单中心研究
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 Epub Date: 2023-08-29 DOI: 10.15605/jafes.038.02.18
Korawan Chawalitmongkol, Kunlatida Maneenil, Pravinwan Thungthong, Chaicharn Deerochanawong

Objective: This study aimed to explore the prevalence and associated factors of thyroid dysfunction among cancer patients treated with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs).

Methodology: A cross-sectional study was done in patients who received TKIs at Rajavithi Hospital in 2019. For patients treated with ICI, a retrospective chart review for patients seen in 2018 to 2019 was conducted. If there were abnormal thyroid function tests (TFT), thyroid autoantibodies were tested.

Results: There were 144 patients on TKIs with a mean age of 56.0 years. Thyroid dysfunction was found in 14.6% of patients and most had subclinical hypothyroidism (n = 16, 11.1%). Imatinib (n = 11, 10.8%) and sunitinib (n = 4, 100%) were the 2 most common TKIs given to patients with thyroid dysfunction. Thyroid dysfunction was associated with male sex, chronic kidney disease and hepatitis B virus infection but not with previous thyroid disease and presence of thyroid autoantibodies.There were 18 patients who received ICIs. The mean age was 63.3 years. Twelve patients (66.7%) used programmed cell death protein-1 antibody (anti-PD1), mainly nivolumab. Thyroid dysfunction was found in 50%, which occurred at a median duration of 46 days. Most patients had overt hypothyroidism and 55.6% needed levothyroxine replacement.

Conclusion: Thyroid dysfunctions from TKIs were mostly asymptomatic and mild in severity. Some types of TKIs might be associated with thyroid dysfunction. On the other hand, thyroid dysfunction from ICIs usually occurs within 6 months and requires levothyroxine replacement.

目的:本研究旨在探讨酪氨酸激酶抑制剂(TKIs)和免疫检查点抑制剂(ICIs)治疗的癌症患者甲状腺功能障碍的患病率及其相关因素。方法:对2019年在Rajavithi医院接受tki治疗的患者进行了一项横断面研究。对于ICI治疗的患者,对2018年至2019年的患者进行了回顾性图表回顾。如有甲状腺功能试验(TFT)异常,检测甲状腺自身抗体。结果:144例TKIs患者,平均年龄56.0岁。14.6%的患者存在甲状腺功能障碍,大多数患者存在亚临床甲状腺功能减退(n = 16, 11.1%)。伊马替尼(n = 11, 10.8%)和舒尼替尼(n = 4, 100%)是甲状腺功能障碍患者最常用的两种TKIs。甲状腺功能障碍与男性、慢性肾脏疾病和乙型肝炎病毒感染有关,但与既往甲状腺疾病和甲状腺自身抗体的存在无关。18例患者接受了ICIs。平均年龄63.3岁。12例(66.7%)患者使用程序性细胞死亡蛋白-1抗体(抗pd1),主要是纳武单抗。50%的患者出现甲状腺功能障碍,中位持续时间为46天。大多数患者有明显的甲状腺功能减退,55.6%的患者需要左旋甲状腺素替代。结论:tki患者甲状腺功能障碍多无症状,严重程度较轻。某些类型的tki可能与甲状腺功能障碍有关。另一方面,ICIs引起的甲状腺功能障碍通常在6个月内发生,需要左旋甲状腺素替代。
{"title":"Prevalence and Associated Factors for Thyroid Dysfunction Among Patients On Targeted Therapy for Cancers: A Single-Center Study from Thailand.","authors":"Korawan Chawalitmongkol, Kunlatida Maneenil, Pravinwan Thungthong, Chaicharn Deerochanawong","doi":"10.15605/jafes.038.02.18","DOIUrl":"10.15605/jafes.038.02.18","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to explore the prevalence and associated factors of thyroid dysfunction among cancer patients treated with tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs).</p><p><strong>Methodology: </strong>A cross-sectional study was done in patients who received TKIs at Rajavithi Hospital in 2019. For patients treated with ICI, a retrospective chart review for patients seen in 2018 to 2019 was conducted. If there were abnormal thyroid function tests (TFT), thyroid autoantibodies were tested.</p><p><strong>Results: </strong>There were 144 patients on TKIs with a mean age of 56.0 years. Thyroid dysfunction was found in 14.6% of patients and most had subclinical hypothyroidism (n = 16, 11.1%). Imatinib (n = 11, 10.8%) and sunitinib (n = 4, 100%) were the 2 most common TKIs given to patients with thyroid dysfunction. Thyroid dysfunction was associated with male sex, chronic kidney disease and hepatitis B virus infection but not with previous thyroid disease and presence of thyroid autoantibodies.There were 18 patients who received ICIs. The mean age was 63.3 years. Twelve patients (66.7%) used programmed cell death protein-1 antibody (anti-PD1), mainly nivolumab. Thyroid dysfunction was found in 50%, which occurred at a median duration of 46 days. Most patients had overt hypothyroidism and 55.6% needed levothyroxine replacement.</p><p><strong>Conclusion: </strong>Thyroid dysfunctions from TKIs were mostly asymptomatic and mild in severity. Some types of TKIs might be associated with thyroid dysfunction. On the other hand, thyroid dysfunction from ICIs usually occurs within 6 months and requires levothyroxine replacement.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 2","pages":"77-85"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138478867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Children with Newly Diagnosed Type 1 Diabetes Mellitus in Brunei Darussalam. 文莱达鲁萨兰国新诊断1型糖尿病儿童的特点
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 Epub Date: 2023-08-02 DOI: 10.15605/jafes.038.02.02
Chun Yen Wee, Alice Moi Ling Yong, Chee Fui Chong, Ing Shian Soon

Objective: This study aims to characterize the presentation, biochemical status of children with T1DM at diagnosis, the type of subcutaneous insulin regimens initiated, and to determine the incidence of T1DM in Bruneian children aged 18 years and younger.

Methodology: A retrospective electronic and paper medical chart review was performed on patients aged 18 years and younger diagnosed with T1DM from 2013 to 2018 in Brunei Darussalam.

Results: A total of 31 children with a mean age of 10.2 ± 3.6 years old were diagnosed with T1DM, of which 66.7% presented with diabetic ketoacidosis (DKA), a majority in severe DKA with an intercurrent illness (p = 0.021). The mean HbA1c was 13.6 ± 2.7% with a mean serum glucose of 37.0 ± 14.9 mmol/L at diagnosis. In the majority of the children (67.7%), multiple daily injections of subcutaneous insulin were initiated. The incidence of T1DM in children aged 18 years and younger was 4.9 per 100,000 for the year 2018.

Conclusions: The majority of the patients in this study presented with severe DKA with an intercurrent illness. This highlights the importance of childhood T1DM awareness among the public and healthcare providers. The incidence of childhood T1DM in Brunei Darussalam is similar to other countries in the Asian region, being relatively low, compared to the rest of the world.

目的:本研究旨在描述T1DM儿童的表现、诊断时的生化状态、开始皮下胰岛素治疗的类型,并确定18岁及以下文莱儿童T1DM的发病率。方法:对2013年至2018年在文莱达鲁萨兰国诊断为T1DM的18岁及以下患者进行回顾性电子和纸质病历回顾。结果:共31例T1DM患儿,平均年龄10.2±3.6岁,其中66.7%的患儿表现为糖尿病酮症酸中毒(DKA),以重度DKA合并疾病居多(p = 0.021)。诊断时平均HbA1c为13.6±2.7%,平均血清葡萄糖为37.0±14.9 mmol/L。大多数儿童(67.7%)开始每日多次皮下注射胰岛素。2018年,18岁及以下儿童的T1DM发病率为每10万人4.9例。结论:本研究中大多数患者表现为严重的DKA并伴有疾病。这突出了公众和医疗保健提供者对儿童T1DM认识的重要性。与世界其他地区相比,文莱达鲁萨兰国儿童T1DM的发病率与亚洲地区其他国家相似,相对较低。
{"title":"Characteristics of Children with Newly Diagnosed Type 1 Diabetes Mellitus in Brunei Darussalam.","authors":"Chun Yen Wee, Alice Moi Ling Yong, Chee Fui Chong, Ing Shian Soon","doi":"10.15605/jafes.038.02.02","DOIUrl":"10.15605/jafes.038.02.02","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to characterize the presentation, biochemical status of children with T1DM at diagnosis, the type of subcutaneous insulin regimens initiated, and to determine the incidence of T1DM in Bruneian children aged 18 years and younger.</p><p><strong>Methodology: </strong>A retrospective electronic and paper medical chart review was performed on patients aged 18 years and younger diagnosed with T1DM from 2013 to 2018 in Brunei Darussalam.</p><p><strong>Results: </strong>A total of 31 children with a mean age of 10.2 ± 3.6 years old were diagnosed with T1DM, of which 66.7% presented with diabetic ketoacidosis (DKA), a majority in severe DKA with an intercurrent illness (<i>p</i> = 0.021). The mean HbA1c was 13.6 ± 2.7% with a mean serum glucose of 37.0 ± 14.9 mmol/L at diagnosis. In the majority of the children (67.7%), multiple daily injections of subcutaneous insulin were initiated. The incidence of T1DM in children aged 18 years and younger was 4.9 per 100,000 for the year 2018.</p><p><strong>Conclusions: </strong>The majority of the patients in this study presented with severe DKA with an intercurrent illness. This highlights the importance of childhood T1DM awareness among the public and healthcare providers. The incidence of childhood T1DM in Brunei Darussalam is similar to other countries in the Asian region, being relatively low, compared to the rest of the world.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 2","pages":"8-12"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692410/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138480012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular Basis of Endocrine-related Disorders. 内分泌相关疾病的分子基础。
IF 0.7 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-01 DOI: 10.15605/jafes.037.S9
Pia D Bagamasbad
{"title":"Molecular Basis of Endocrine-related Disorders.","authors":"Pia D Bagamasbad","doi":"10.15605/jafes.037.S9","DOIUrl":"https://doi.org/10.15605/jafes.037.S9","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"38 1","pages":"4"},"PeriodicalIF":0.7,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fd/26/JAFES-38-S1-4.PMC10207864.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9902425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the ASEAN Federation of Endocrine Societies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1